Broker Ratings

AptarGroup, Inc. – Consensus ‘buy’ rating and 11.0% Upside Potential

AptarGroup, Inc. which can be found using ticker (ATR) now have 4 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between 152 and 125 calculating the average target price we see $139.75. Now with the previous closing price of $125.93 this would indicate that there is a potential upside of 11.0%. The 50 day moving average now sits at $123.08 and the 200 day moving average is $116.54. The total market capitalization for the company now stands at 8.25B. The stock price is currently at: 125.64 USD

The potential market cap would be $9,151,661,029 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 33.24, revenue per share of 51.83 and a 5.73% return on assets.

AptarGroup, Inc. is a designer and manufacturer of a range of drug delivery and consumer product dispensing, sealing and active packaging solutions and services. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma includes operations that sells dispensing systems and sealing solutions and also manufactures and sells elastomeric primary packaging components. The Company’s products include stoppers for infusion, antibiotic, lyophilization and diagnostic vials. The Aptar Beauty segment includes operations that sell dispensing systems, drug delivery systems, sealing solutions and services to the prescription drug, consumer health care, injectables, and active material science solutions markets. The Aptar Closures business serves multiple markets, including food, beverage, personal care, home care, beauty and healthcare. This segment offers food protection business and elastomeric flow-control technology business.

Share on:
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    AptarGroup, Inc. (ATR) Stock Analysis: Strong Buy Ratings and 35.85% Potential Upside

    AptarGroup, Inc. (NYSE: ATR) is capturing the attention of investors with its solid position in the healthcare sector, specifically within the medical instruments and supplies industry. As a leading designer

    AptarGroup, Inc. (ATR) Investor Outlook: Strong Buy Ratings and 34% Upside Potential

    AptarGroup, Inc. (NYSE: ATR) is making waves in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. With a robust market capitalization of $8.63 billion, this Crystal Lake,

    AptarGroup, Inc. (ATR) Stock Analysis: Exploring a Potential 32.76% Upside for Investors

    AptarGroup, Inc. (NYSE: ATR) is making waves in the healthcare sector with its diversified portfolio of drug delivery and consumer product dispensing solutions. Headquartered in Crystal Lake, Illinois, AptarGroup serves

    AptarGroup, Inc. (ATR) Stock Analysis: Discover Its 33.69% Potential Upside

    AptarGroup, Inc. (NYSE: ATR), a leading player in the healthcare sector, specifically within the Medical Instruments & Supplies industry, has been capturing investor attention with a market cap of $8.72

    AptarGroup, Inc. (ATR) Stock Report: Analyzing a 33.69% Upside Potential for Investors

    AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, stands out within the medical instruments and supplies industry. With a robust market capitalization of $8.72 billion, the company

    AptarGroup, Inc. (ATR) Stock Analysis: Potential 31.55% Upside Captivates Investors

    AptarGroup, Inc. (NYSE: ATR) is making waves in the healthcare sector with its innovative solutions in drug delivery and consumer product dispensing. As a leading player in the medical instruments

      Search

      Search